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ABSTRACT
EFFECT OF ANTIGENIC SITE MUTATIONS ON THE BINDING SPECIFICITY OF
AN ANTI-HEMAGGLUTININ ANTIBODY TO H3N2 INFLUENZA VIRUS
ISOLATES
By
Juliana Liambaya Hagembe

The hemagglutinin (HA) is the main antigenic glycoprotein found on the surface of the
influenza virus and contains a sialic acid receptor-binding site that allows binding of the
virus to a host cell. This important role makes it an ideal target for neutralizing
antibodies. However, its ability to mutate and change every year at antigenic sites reduce
or inhibit the binding of anti-hemagglutinin neutralizing antibodies, thereby allowing new
subtypes to spread within non-immune species. Understanding the effect mutations of
HA to antibody binding specificity, is not only fundamental to understanding the
biological processes but also helpful in inhibitor design through rational design.
Molecular Dynamics simulations and Molecular Mechanics-Poisson Boltzman Surface
area (MM-PBSA) free energy calculations were used to study and compare the energetics
of the binding of HAs from seven, Hong Kong, influenza, H3N2 Isolates from 1968,
1969, 1974, 1975, 1985, 1992, 1999 to the A/AICHI/68 (H3N2) anti-HA antibody. This
study provides a bit more insight on the trend of mutations of HA and the route of
evolution of influenza viruses. Results show an overall decrease in binding energy with
increase in mutations and year progression. In addition, the association of HA to the
antibody is driven by highly favorable van der Waals interactions whereas solute and
solvent electrostatic energies contributed unequally to binding.
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INTRODUCTION

Interactions between proteins play an essential role in many biological processes
such as enzyme regulation, signal transduction and immune response. The binding of two
structurally different proteins to a similar surface has been described on several
occasions. Some of the interactions studied concern complexes between antigen and
antibody where one of the wild-type molecular partners is able to bind to structural
variants of the other: in most cases, these wild-type counterparts are formed by proteins
with only a few amino acids difference 1-3. Understanding how protein complexes form
and what determines their specificity, binding constants and substitutions is not only
fundamental to biological interpretation of the processes but also helpful in inhibitor
design through a rational approach 4, 5. The influenza virus, which creates multiple
problems due to its ability to mutate and change every year, is a prime candidate for such
a study.
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1.1 Influenza Virus
1.1 1 Influenza virus overview
The influenza virus is a respiratory pathogen that causes influenza, an acute
respiratory disease with prominent systemic symptoms. A wide variety of warm-blooded
animals including birds, various wild and domesticated mammals and humans are
vulnerable to infection by the virus. In humans, in addition to the symptoms directly
attributable to infection by the influenza virus, the patient will also be at risk for
complications such as the onset of pneumonia 6. This is a particularly serious
complication for the elderly and others with immuno-compromised systems. Today,
pneumonia and influenza are listed as leading causes of death in the United States,
responsible for 50,000 to 70,000 deaths annually 7. The seasonal nature of influenza, the
ease of transmission, the high rates of fatalities that it causes among the elderly and
among patients under 5 years of age, have made influenza a key public health concern 8.
The Orthomyxovirus genus, to which influenza belongs, consists of three species:
A, B, and C, each distinguished by antigenic differences in two of their stable internal
proteins, Nucleoprotein (NP) and Matrix protein (M) 9. In addition, the viruses differ in
their pathogenicity and genome organization. Type A viruses are found in a wide variety
of warm blooded animals including birds and humans and causes periodic worldwide
epidemics (pandemics) in their host organisms, whereas types B and C are chiefly human
pathogens and rarely cause pandemics 10. The viruses of this genus are most commonly
spherical (filamentous forms may also occur), approximately 80 nm to 120 nm in
diameter, and have an eight-fold segmented, single-stranded RNA genome with negative
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polarity containing between 890 and 2341 nucleotides each. An excellent review on the
structure and replication strategy of influenza viruses has been published recently 11.
The virus has a core ribo-nucleoprotein that contains the genetic information of
the virus wrapped up in protein. The eight separate viral RNA segments of the antisense
RNA of both the influenza A and B virus (Figure 1), each code for a functionally
important protein. The virus even with a fairly small genome is able to encode for a
variety of proteins using different reading frames and alternate RNA splicing. The
proteins encoded by the RNA segments include; Polymerase B2 protein (PB2),
Polymerase B1 (PB1), Polymerase A (PA), Hemagglutinin (HA), Nucleocapsid protein
(NP), Neuraminidase (NA or N) and Matrix protein (M). Each RNA segment is
encapsulated by the NP to form the ribo-nucleoprotein (RNP) complex.

Figure 1: A diagrammatic representation of influenza A and B virus showing protein and RNA
composition (Polymerase B2 (PB2), Polymerase B1 (PB1), Polymerase A (PA), Hemagglutinin (HA),
Nucleocapsid (NP), Neuraminidase (NA or N), Non structural proteins (NS), Hemagglutinin (HA), and
Matrix protein (M)).
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The active RNA polymerase, which is responsible for replication and
transcription, is formed from PB2, PB1 and PA. In addition to the polymerase activity, it
has an endonuclease activity and is linked to the ribo-nucleoprotein. The NS1 and NS2
proteins have a regulatory function to promote the synthesis of viral components in the
infected cell. The NP encapsulates each RNA segment thus forming a nucleocapsid. The
nucleocapsid is surrounded by a shell of two Matrix proteins (M1 and M2). M1
constructs the matrix; and in influenza A viruses, M2 acts as an ion channel pump to
lower or maintain the pH of the endosome of the infected cell. Overlying the matrix is the
viral envelope consisting of a lipid bilayer, which has multiple copies of glycoproteins
radiating from its surface. The characteristic rod-shaped "spikes” are HA and the
interspersed mushroom-shaped clusters are NA. These HA and NA molecules are thought
to pass through the envelope and interact with the underlying matrix protein.
HA and NA are the major antigens in influenza. HA mediates the first stages of
virus infection; sialic acid binding and virus-cell membrane fusion 12, whereas NA is
concerned with the release of progeny virions from the cell surface 13. NA acts as an
enzyme, cleaving sialic acid from the HA molecule, from other NA molecules and from
glycoproteins and glycolipids at the cell surface 14. The HA and the NA are used to
further subdivide the influenza A virus into additional subtypes 15. Currently 15 subtypes
of HA (HI-H15) and nine subtypes of NA (N1-N9) have been discovered. The influenza
virus continuously undergoes antigenic drift and antigenic shift to escape the host’s
acquired immunity. The two glycoproteins are constantly subjected to selection pressure
by the host’s defense mechanism. Antigenic drift, the accumulation of mutations in all
influenza gene segments, is particularly prevalent in the surface glycoproteins (HA and
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NA) 16-21. The main cause of point mutations is thought to be due to a lack of
proofreading ability by the RNA-dependent polymerase complex 22. Antigenic shift, on
the other hand, occurs as a result of genetic re-assortment of the genome segments from
different influenza viruses. Antigenic shift causes the extinction of the current strain of
the influenza virus due to replacement of the strain specific glycoprotein’s (HA or NA)
with new ones 23. The source and host of such new viruses is thought to be animals such
as birds or pigs.
To adequately describe a particular influenza virus isolate, the influenza virus
type, the host species (omitted in the case of human origin), the geographical site of first
isolation, serial number and year of isolation must be mentioned. In the case of influenza
virus type A, the nomenclature also includes HA and NA subtypes in brackets. One of the
parental avian strains of the current outbreaks of H5N1 of Asian lineage was isolated
from a goose in the Chinese province, Guangdong: accordingly, it is designated
A/goose/Guangdong/1/96 (H5N1) (Xu 1999), while the isolate originating from the
human case of Asian lineage H3N2 infection from Aichi (1968) is referred to as
A/Aichi/68 (H3N2).
So far only three HA subtypes and NAs from two subtypes have caused human
pandemics: H1N1 in 1918, H2N2 in 1957 and H3N2 in 1968. Three small outbreaks have
also arisen from avian subtypes (H5, H7, and H9). The avian subtypes managed to make
a direct leap to humans from birds but their low transmissibility prevented major
epidemics 24. The next expected pandemic threat at the moment is from the H5N1 (bird)
or H1N1 (swine) virus subtype 25.
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Vaccination is the primary method for preventing influenza and its implications.
So far inactivated-virus vaccines have provided essential protection when the vaccine
antigens and the circulating viruses share high degree of similarity in the HA protein.
Since new influenza virus antigenic variants emerge frequently from accumulation of
point mutation in the HA protein (i.e. antigenic drift), influenza vaccines need to be
updated frequently based on the results of global influenza surveillance; including
clinical, virological and immunological surveillance. In virological surveillance,
influenza viruses are characterized antigenically on the basis of the ferret serum antibody
cross- reactivity. Antigenic variants selected serologically are then tested for antibody
cross- reactivity in human sera to evaluate the potential cross-protection against the
antigenic variant provided by the current vaccines and to select vaccine strains for the
next season 7, 26.

1.1.2 Hemagglutinin overview
HA is the main influenza antigenic glycoprotein found on the surface of the
influenza viruses (as well as many other bacteria and viruses) and plays an important role
in virus life cycle. The term "hemagglutinin” arises from the protein's ability to cause red
blood cells (erythrocytes) to clump together ("agglutinate") in vitro. The protein contains
a sialic acid (N-acetylneuraminic acid) binding site, which allows binding of the virus to
the cell that is being infected. It also induces membrane fusion allowing release of viral
RNPs in to the cellular cytoplasm 1, 27. The body of the HA molecule contains the stalk
region and the fusiogenic domain that allows membrane fusion needed for the virus to
enter a new cell. It consists of 562 - 566 amino acids, with a molecular weight of
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approximately 220 kDa and has either two or three glycosylation sites 28, 29. It spans the
lipid membrane so that the major part, which contains at least 5 antigenic domains, is
presented at the outer surface 30. These antigenic sites, which surround the host receptorbinding site, are presented at the head of the molecule, while the feet are embedded in the
lipid layer. Prominent mutations in the antigenic sites reduce or inhibit the binding of
neutralizing antibodies, thereby allowing a new subtype to spread within a non-immune
species 22, 31.

1.1.3 Hemagglutinin Structure
The atomic structure of HA was first published in 1981 by Wilson, Wiley and
Skehel to a resolution of 3 Angstroms 1. This was the first look at the structure of a viral
membrane protein. They found that HA is an elongated homotrimeric 27 integral
glycoprotein that is shaped like a cylinder and measures 135 Å from insertion in the
envelope membrane to its tip.
Receptor binding site

Cleavage
site
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Figure 2: Ribbon representation of HA0 trimmer
influenza virus. Each monomer (colored
differently) possesses two important sites: 1) The
'Receptor binding site' for virus attachment to the
host lung epithelial cells via sialic acid
containing host cell receptors. 2) The 'cleavage
site' where for full infectivity, the single chain
(HA0) is cut into two chains (HA1 & HA2). At
the N-terminal end of the HA2 chain is the
fusion peptide, which is critical for subsequent
membrane fusion events that lead to infection.
(Image created and modified using RasMol
[PDB 1HGF] 32).

The trimmer contains two distinct regions; a stem consisting of a triple stranded
coiled-coil of alpha helices extending 76 Å from the membrane and a globular region of
anti-parallel beta-sheet on top. The conserved host-receptor binding site was found to be
located on the top globular portion. It is the amino acids that surround this region that
have undergone change in most of the antigenic variants appearing in influenza virus
epidemics. Each of the three monomeric subunits is synthesized as a precursor that is
glycosylated and then cleaved into two smaller polypeptides (the HA1 and HA2 subunits).
The six resulting chains are three HA1s and three HA2s.

Figure 3: Ribbon diagram representation of HA
showing the chains that result in the event of
proteolytic cleavage of a trimmeric precursor
protein. Three green HA1 and three red HA2’s
(Image created and modified using RasMol
[PDB 1HGF]).

The HA2 is a helical chain anchored in the membrane and is topped by a large
HA1 globule. The HA1 subunit (328 residues) is an elongate structure reaching from the
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N-terminus at the viral membrane end of the molecule along the stem of the subunit
before forming a globular tip. It then returns part way down the stem of the monomer,
ending at the C-terminus part of its distal end. The HA1 subunit forms an 8-stranded antiparallel beta-sheet motif known as a "jelly roll."

Figure 4: HA monomer, showing
the HA1 subunit (328 residues), an
elongate structure reaching from
the red N terminus at the viral
membrane end of the molecule
along the stem of the subunit
before forming a globular tip and
then returning part way down the
stem of the monomer, ending at the
yellow terminus tip. The long
alpha-helix of H2 can also be seen
(cyan). (Image created and
modified using RasMol [PDB
1HGF]).

The loop that separates the 3rd and 4th strand of the jellyroll contains a short αhelix. Residues from one side of this α-helix and from residues near the top of the
jellyroll form a pocket that is the sialic acid binding site for each monomer of the
hemagglutinin trimmer. The binding sites contain the conserved amino acids - Y98,
W153, H183 and Y195 – that form the base of the site which is limited at the top by a
short α-helix (the 190-helix, residues 190–198), a loop-like structure at the front edge (the
9

130-loop, residues 133–138) and another loop that forms the left edge, near the
intersubunit interface (the 220-loop, residues 220–229) 33. Antigenic sites, which
surround the host receptor-binding site, are presented at the head of the molecule. The
receptor-binding sites in all HAs are at the membrane distal tip of each subunit in the
trimer. Antigenic sites (antibody binding sites) residues in the HA1 chain, previously
described by Brownlee and Fodor 34 are grouped into 5 regions: Ca1 (169 to 173, 208 to
296, 238 to 240), Ca2 (140 to 145, 224 to 226), Cb (78 to 83), Sa (128 to 129, 156 to 160,
162 to 167), and Sb (187 to 198)
‘Fixed’ changes, i.e. changes retained in HAs of viruses isolated in subsequent
years, involved residues on the surface of HA, whereas about two-thirds of those not
retained were found to be buried. These ‘fixed’ substitutions are thought to have been
selected because they prevent antibody binding. This hypothesis is supported by the
coincidence of the locations of these substitutions with the locations of amino acid
substitutions detected in antigenic variant HAs that were selected by growing virus in the
presence of monoclonal anti-HA antibodies 12, 35.
A notable feature of the HA2 subunit (221 residues) is the two anti-parallel α helices that form part of the stem of the molecule. One of the helices is among the longest
known in globular proteins (75Å). The HA1 and HA2 chains of each monomer are
connected via a single disulfide bond. The HA2 subunit terminates in an α-helical
structure near the protease cleavage site. The hemagglutinin trimmer is stabilized from
interactions between the major HA2 α -helices in the formation of a triple-stranded coiled
coil in the trimmer’s interior. The N-terminal (top) half of the coiled-coil super helix is
tightly packed with several nonpolar residues in van der Waals contact around the three-
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fold axis. The C-terminus end of the super helix expands away from the axis with polar
and charged residues from each monomer experiencing electrostatic repulsion from like
residues in the other monomers
The influenza virus binds to the cell surface by fixing the outer top of the HA to
the sialic acid of a cell’s glycoproteins and glycolipids. The sialic acid linkage to the
penultimate galactose, either α 2→3 (in birds) or α 2→6 (in humans), determines host
specificity 33, 36-38. Avian influenza viruses generally show the highest affinities for α
2→3 linked sialic acid. In birds targeted by these viruses, α 2→3 linked sialic acid is the
dominating receptor type in epithelial tissues of endodermic origin (gut, lung). In
contrast, human-adapted influenza viruses, primarily access α 2→6 linked residues which
predominate on non-ciliated epithelial cells of the human airway. The different receptor
preferences help in preventing hassle-free transmission of avian viruses to humans thus
creating a species barrier 39. However, recently, it was shown that there is a population of
ciliated epithelial cells in the human trachea, which also carry avian receptor-like glycoconjugates at lower densities 40, 41. Also chicken cells carry human-type sialic receptors at
low concentrations. In pigs and quails, both receptor types are present at higher densities,
thus making these species great hosts for mixing avian and human strains 42.
After attachment, the cell via a clathrin-coated pit receptor-mediated endocytosis
process, as shown in Figure 6, takes up the virus. The time from entry to production of
new virus is on average six hours 12
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Figure 6: Replication cycle of influenza A virus. Binding and entry of the virus, fusion with endosomal
membrane and release of viral RNA, replication within the nucleus, synthesis of structural and enveloped
proteins, budding and release of virions capable of infecting neighboring epithelial cell 43.

1.1.4 Neutralization of Infectivity by Antibodies
Since viral attachment to cells is the first step in the infectious cycle, its inhibition
would appear to be an effective way of preventing infection. HA contains the receptor
binding site and studies have shown that anti-hemagglutinin antibodies neutralize virus
infectivity in vitro, in addition to providing protection against infection 44. A direct
correlation between inhibition of virus binding to cells and neutralization of infectivity
has been shown 45. There are however, uncertainties about the mechanism of
neutralization of influenza virus. Knoswo et al determined the structures of HA-AB
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complexes with three distinct antibodies and was able to provide more insight on the
mechanism by which anti HA antibodies neutralize infectivity 44. The epitopes
recognized by three antibody studies were located on the receptor-binding domain. Two
of them overlapped with the receptor-binding domain and blocked access to it while the
third had the ability to prevent the structural transition of HA that is required for fusion of
virus and cellular membranes 46-48. These three antibodies are thought to be representative
of the range of neutralizing antibodies that react with HA.
The fact that the affinities of antibodies for HA are much stronger than the
affinities of the receptor-binding site for sialic receptor analogues, allows antibodies to
effectively block receptor binding. Comparison of the sizes of the receptor-binding site
(800 Å2) 33 , and of antibody–antigen interfaces of the monoclonal antibodies that
contact amino acid residues that are components of the receptor-binding site, indicates
that ‘antibody footprints’ (1200 and 1500 Å2 ) 20, 49 are larger. Therefore, in addition to
covering the receptor-binding site, the antibody would also cover HA residues that are
not involved in binding to receptor. Mutations at these positions are what allow virus to
escape neutralization without imposing selective pressure on residues of the receptorbinding site that could compromise its activity. Support for these conclusions is provided
by the findings that the receptor-binding site is formed by conserved residues and that all
the mutations which allow the virus to escape neutralization by antibodies that partially
overlap the receptor-binding site, are at positions outside the site 48.
The relationship between antigenicity and immunogenicity remains unclear as our
knowledge of the determinants of HA immunogenicity and of other factors that lead to
the induction of antibodies with varying ranges of specificity in different infected
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members of the population, is incomplete. It is nevertheless essential for an
understanding of the pathway of antigenic drift and possibly also for attempts at effective
vaccination of all sections of the population. Among the initial steps towards
understanding antigenicity, is the comparison of antibody binding specificity towards
different mutated HAs. The purpose of this study was to collect information regarding the
change in binding specificity of HA to a specific antibody due to antigenic mutation of
HA. Such information might enable prediction of subsequent structural and antigenic
changes, as no identification of mutation preference or the ability to predict changes has
been achieved. As a complementary approach to in vitro experiments (e.g. isothermal
titration chemistry), molecular dynamics (MD) simulations could provide such
information.

1.2 Computer Molecular Modeling
1.2.1 Molecular Modeling
Molecular modeling is a multidisciplinary field that encompasses laws and
theories that stem from mathematics, physics, chemistry and biology and employs
algorithms from computer science and information theory. It can be defined as the art and
science of studying molecular structure and function through theoretical and
computational techniques by building models or mimicking the behavior of molecules.
The role of computation in biology and biological chemistry has shown a steady
increase over the past decades due to continued growth of computing power, in particular
in the context of personal computers. Simulations that were difficult for yesterday’s super
computers can be carried out today using standard office workstations. Use of parallel
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computers, which couple processors together in such a way that calculation is divided
into small pieces with results being combined at the end, has also enhanced the ability to
analyze, compare, and characterize large and complex data sets that are obtained from
experiments on bimolecular systems.
In addition, the ability of computer simulations to complement experiments by
providing averages and confirming distributions or interactions between parts of the
system for a variety of properties of bimolecular systems that cannot be measured by
experimental means, have rendered the method invaluable.
As a counterpart to experiments, Molecular Dynamic (MD) simulations are used
to estimate equilibrium constants and dynamic properties of complex systems that cannot
be calculated analytically. Modeling approaches thus symbolize the exciting interface
between theory and experiment by filling in the many gaps, thus enabling building of
better models and theories that ultimately make (testable) predictions 50, 51.

Molecular modeling studies usually involve three stages. In the initial stage, a
model is selected to describe the intra and inter-molecular interactions in the system. The
two most commonly used models are quantum mechanics and molecular mechanics; both
enable the energy of any arrangement of atoms and molecules in the system to be
calculated. They also allow the determination of energy variation in the system as
positions of atoms and molecules change. The second stage is the calculation itself.
Calculations such as energy minimizations, molecular dynamics and Monte Carlo
simulation/conformation can be made. The last stage involves analysis of the calculation;
to not only calculate properties, but to check that it was performed properly.
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1.2.2 Biomolecular Force Fields (Molecular Mechanics)
The potential energy of intramolecular and intermolecular interactions is one of
the most important variables in computer modeling. Molecular mechanics is based upon a
rather simple model of these interactions within a system in addition to contributions
from stretching of bonds, the opening and closing of angles and rotations about single
bonds.
The basic concept is that, given a molecular structure (i.e., cartesian or internal
coordinates for all the atoms), we can calculate the energy of interaction between all
atoms. In this way, the energy values of the molecular conformations found in nature can
be calculated. The intermolecular energy between two molecules interacting such as a
drug molecule interacting with proteins or two proteins interacting with each other can
also be calculated. The molecular potential energy is presumed to be a sum of energy
terms that correspond to physical effects such as electrostatic interactions, dispersion and
repulsion energies, bond distance and bond angle distortion. The energy is assumed to be
a function of the number and type of chemical species within the molecule and the
distance between all pairs of atoms (see equations below).

E = Ebonds + Eangle + Edihedral + Enon − bonded

Enon − bonded = Eelectrostatic + Evan der Waals

The set of parameters consisting of equilibrium bond lengths, bond angles, partial
charge values, force constants and van der Waals parameters are collectively known as
force fields and can be better described as the functional form and parameter sets used to
denote the potential energy of a system of particles. Different implementations of
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molecular mechanics use slightly different mathematical expressions, thus different
constants for the potential functions. It should be noted that transferability is a key
attribute of a force field, as it enables a set of parameters developed and tested on a
relatively small number of cases to be applied to a much wider range of molecules.

The common force fields in use today were developed by using high-level
quantum calculations and/or fitting experimental data. Only if constructed and
parameterized correctly will the energy models generate reliable structural predictions.
There are a number of complete sets of energy parameters available, which describe
different interactions between, for example, all atoms in a protein or nucleotide. These
force fields have their roots on the pioneering work of Momany et al. 52, 53 and
Lifson/Hageler et al. 54. Momany and his coworkers developed the Emperical
Comformational Energy program for Peptides Potential (ECEPP) by starting from
accurate geometric data for all amino acids while keeping bond lengths and bond angles
fixed and terms optimized to crystal packing data, while, Lifson and Hagler developed an
empirical data set for amides and carboxylic acids where a limited set of parameters
(including partial charges, but without special hydrogen parameters) was determined by
least squares fitting to crystal structures, lattice energies and a few dipole moments.
The force field used in this study is AMBER 55, an acronym for Assisted Model
Building and Energy Refinement. It is a family of force fields for molecular dynamics of
biomolecules originally developed by the Peter Kollman’s group at the University of
California, San Francisco and also refers to the molecular dynamics simulation package
that implements these force fields.
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The functional form of the AMBER force field 56 is:
V (rN)=Vbonded + Vnonb

Vbonded =∑bonds Kb (d-do) + ∑angles Ka (θ- θo) +1/2 ∑dihedrals Kd (1+cos (mΦ –γ)
Vnonb =∑nonbo (A/r12 –B/r6 + qiqj/4Πε0 rij )

V denotes the potential energy, which is a function of the positions (r) of N
particles (usually atoms). The various contributions are schematically represented in
Figure 7.

The first term in the equation, ∑bonds Kb (d-do), represents the energy between
covalently bonded atoms. The two parameters that define the bond are the force constants
Kb and do. The interactions between a pair of bonded atoms is modeled by a harmonic
potential that gives the increase in energy as the bond length d deviates from the
reference, do. The force is a good approximation near the equilibrium bond length, but
becomes increasingly poor as atoms separate.

The second term ∑angles Ka (θ- θo) is an energy summation over all valence angles
in a molecule and is again modeled using a harmonic potential and requires two
parameters; Ka is a force constant and is an ideal bond angle while θo depends primarily
on the hybridization of the central atom in the angle.

The third term 1/2 ∑dihedrals Kd (1+cos (mΦ –γ) , represents the energy of twisting
a bond due to bond order ( single or double bonds) and neighboring bond or lone pairs of
electrons. It is a torsional potential and models how the energy changes as the functional
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groups at either end of a bond rotate relative to each other. Each dihedral in the molecule
requires three parameters to calculate the energy of the angle, a rotational barrier (Kd),
number of local minima(m), and the value of the dihedral angle at which the energy is a
minimum (related to γ).
The fourth and last contribution ∑nonbo (A/r12 –B/r6 + qiqj/4Πε0 rij) is the nonbonded term. It represents the non-bonded energy between all atom pairs that are in
different molecules or that are in the same molecule but are separated by at least three
bonds. The non bonded term can be decomposed into van der Waals interactions,
modeled by using Lennard-Jones potential 57 and electrostatic energies, modeled using a
Coulomb potential 58, 59 term where r is the inter-atomic distance between two ions, qi
and q2 the electric charges in coulombs carried by atoms 1 and 2 respectively, and ε0 is
the electrical permittivity of space. The electrostatic interaction is neglected for atoms
sharing a common bond or bond angle. The parameter A accounts for intermolecular
repulsion at short distances. The parameter B accounts for attractive dispersion forces.

Figure 7: Schematic
representation of the
four key contributions
to a molecular
mechanics force field;
bond stretching, angle
bending, torsional terms
and non-bonded
interactions.
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1.2.3 Molecular Dynamics Simulation

The MD approach is simple in principle. A system is stimulated in motion by
following molecular configurations in time according to Newton’s equation of motion
(F=ma) under the influence of a specified force field (which as stated earlier is essentially
the mechanical representation of the system and assumes simple, pair wise –additive
potentials for the system, that expresses how the composite atoms stretch, vibrate, and
rotate about the bonds in response to intramolecular and intermolecular forces). The
result is a trajectory that specifies how the positions and velocities of the particles in the
system vary with time.

A MD trajectory consists of three essential parts: initialization, equilibration, and
production. An initial configuration of the system is first established. An equilibration
phase is then performed, during which the system evolves from the initial configuration.
Thermodynamic and structural properties are monitored during the equilibration until
stability is achieved. At the end of the equilibration, the production phase commences. It
is during the production phase that simple properties (e.g. energy, temperature, pressure
and density) of the system are calculated. At regular intervals, the configuration of the
system is outputted to a disk file. Finally the simulation is analyzed; properties not
calculated during the simulation are determined and the configuration examined both to
discover how the structure of the system changed and check for any unusual behavior that
might indicate a problem with the simulation.

The first stage, initialization, involves specifying the initial coordinates and
velocities for the solute macromolecule and for the solvent and ion atom. The initial

coordinates are either available from experiment (e.g. crystal structures) or can be
acquired through homology modeling. Not surprisingly, the starting coordinates
collected from experiment and homology modeling generally does not correspond to a
minimum in potential energy. This is due to methods used to obtain crystal structures
neglecting effect of solution to structure, thus not encouraging stable states of molecular
system that correspond to local minimum energy. In addition, choice of force field used
to represent crystal structure also affects net potential energy. Minimization (further
refinement) is therefore usually done to relax strained contacts. First order minimization
algorithm (energy minimization techniques) that are frequently used in molecular
modeling to minimize the potential energy include steepest descent and conjugate
gradient minimization techniques 60. These gradually change the coordinates of the atoms
as they move the system closer and closer to a minimum energy. The starting point for
each iteration is the molecular configuration obtained from the previous step. For the first
iteration, the starting point is the initial configuration of the system provided by the user.
Energy minimizations generate individual minimum energy configurations of a system.
In some cases, the information provided by energy minimization can be sufficient to
predict accurately the properties of a system. However, this is possible only for relatively
small molecules of small molecular assemblies in the gas phase where minimum
configurations on energy can be identified and statistical mechanical formulae can be
used to derive a partition function from which thermodynamic properties can be
calculated. To study more complex systems (like the current HA-AB system), energy
minimization techniques prepare the system for other types of calculations (like
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molecular dynamics) by relieving any unfavorable interactions in the initial configuration
of the system.

Many simulations of macromolecules were initially simulated in vacuo due to
computer limitation, but with the realization that most macromolecules are naturally
hydrated and hydration plays a big role of how they function, there was a need to come
up with a way to get the correct balance between water and water solute interaction in the
calculation. This problem was solved with the increase in the power of modern
computers, which has allowed inclusion of explicit solvent (water molecules and counter
ions) around the protein. Choosing the best water model has been a major interest of
research in itself because of the problem of finding a model that can represent the
anomalous properties of water in solid, liquid and gas phases. The current commonly
used models are the SPC mode 61 and TIP3P and TIP4P model 62. In TIP3P model (used
in this study), three sites are used for the electrostatic interactions; the partial positive
charges are partially balanced by an appropriate negative charge located on the oxygen
atom. The van der Waals interaction between two water molecules is computed using a
Lennard-Jones function 57 with just a single interaction point per molecule centered on
the oxygen atom; no van der Waals interactions involving the hydrogen atoms are
calculated.
Figure 8: TIP3P water model. It contains three
simple interaction sites corresponding to the three
atoms of the water molecule. Each atom gets
assigned a point charge, and the oxygen atom also
gets the Lennard-Jones parameters.
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If crystallographic data is used, before continuing with the molecular dynamics,
other factors need to be considered in the initial stages. For example, since the threedimensional structures of biological macromolecules are stabilized by the presence of
hydrogen bonds between secondary structural elements in proteins and between the bases
in DNA and these are usually not included in crystallographic data, they need to be added
in order to do a more accurate simulation. In addition, even though the coordinates of
some of the solvent molecules may be known, it is necessary to add other solvent
molecules to give the appropriate solvent density. This is usually done using the LEaP
program in AMBER or other online programs, for example H++ 63-65.

Design of molecular dynamics simulations should also take into account available
computational power. Simulation size (number of particles), time step and total time
duration must be selected so that the calculation can be completed within a reasonable
time period, but long enough to be relevant to the time scales of the natural process being
studied. The spanning times related to protein dynamics most commonly indicated in
literature vary between several nanoseconds to several microseconds, which take several
CPU days or years. Parallel algorithms are sometimes used that allow the load to be
distributed between CPU’s. Computational costs can also be reduced by employing
electrostatic methods such as the particle mesh Ewald 66, good spherical cut off
techniques or using algorithms such as SHAKE 67, which fix the vibrations of the fastest
atoms (e.g. hydrogen) into place. When a cut off is employed, the interactions between all
pairs of atoms that are further apart than the cut off value are set to zero.
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After doing the MD simulation, there are various different computational
techniques available for use depending on properties to be studied to further predict the
properties of a system like structure prediction, conformational analysis, sequence
analysis, protein folding, solvation energies, and free energies.

1.2.4 Free Energy Calculations
The free energy is often considered the most important quantity in
thermodynamics. The free energy is usually expressed as the Helmholtz function, A (used
for a system with a constant number of particles, temperature and volume – constant
NVT) 68 or the Gibbs function, G ( used for a system with constant number of particles,
temperature and pressure - constant NPT ) 69. Most experiments are conducted under
conditions of constant temperature and pressure, where the Gibbs function is the
appropriate free energy quantity.
Various techniques have been used to predict relative binding free energies of
protein-protein association 70-73. The Molecular Mechanics Poisson Boltzmann/
Generalized Born surface area (MM-PB(GB)SA) 74, 75 method was chosen for this study
as other methods were not considered conducive as they suffer from long computational
times in addition to potential technical difficulties associated with creation and
annihilation of atoms. The MM–PB(GB)SA method is a recently introduced approach to
predict free binding energies of a complex of molecules in solution. The method has been
applied successfully to study protein-peptide, protein-protein, protein ligand, protein
nucleic acid, nucleic acid-ligand interactions, processes such as protein folding, and the
conformation- dependent free energies of nucleic acid. More specifically, the method has
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been used to predict, the relative stabilities of A-DNA and B-DNA, effects of alanine
mutations on protein-protein interactions 76, and binding of steroids to anti-progesterone
and anti-testosterone antibodies 77.
MM-PB(GB)SA approximates free energies using a Poisson-Boltzmann (PB)
continuum or generalized Born (GB) representation of the solvent together with a surface
area-dependent term and molecular mechanics energies using snapshots from MD or
Monte Carlo methods (not discussed) simulations generated with continuum solvent
approaches. All snap shots collected are stored in AMBER format and the molecular
energies are determined with the anal program from AMBER, representing internal
energy (bond, angle and dihedral) and van der Waals electrostatic interactions.
Free energy calculations performed by using the MM-PB(GB)SA approach are
described by Srinivasan et. al 78 and discussed in more detail in the method section. To
use the MM-PB (GB)SA method, the user has to supply:
1) Trajectory files from MD
2) The input files for the anal program
3) The topology files for all interacting molecules without waters or their mutants,
depending on the purpose of the run
4) The files with the charge and van der Waals parameters
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1.3 Research Question/Hypothesis
As stated earlier, the inhibition of binding of the influenza HA to the sialic cell
receptor is an effective way of preventing infection as it contains a sialic acid cell
receptor-binding site. Mutations at these positions causes reduction in antibody affinity,
allowing viruses to escape from neutralization without imposing selective pressure on
residues of the receptor-binding site that could compromise its activity. As a
complementary approach to experiments, molecular modeling and molecular dynamics
simulations using the AMBER force field and MM-PB(GB)SA free energy calculation
method are used to collect information regarding the trend and effect of single and
multiple mutations of HA to antibody binding specificity of seven different isolates of the
influenza virus over a range of 20 years. Virus strains from later years were expected to
have similar or increased affinity to earlier virus-specific antibodies when they no longer
posed a primary threat to the virus survival.
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METHODS

2.1 System set up for MD simulation
2.1.1 Sequence and Data Base Searches and Model Setup
The original influenza isolate chosen to be studied was based on the availability
of a previously published paper46 that described an X-ray crystallographic structure of an
HA-AB complex. From a search of the Protein Data Bank (PDB) data base, initial atomic
coordinates for the antibody complex were obtained from the X-ray crystal structure of a
recombinant influenza strain containing A/Aichi/68 (H3N2) HA complexed with the Fab
fragment of the anti-influenza neutralizing antibody (PDB ID 1EO8) by Fleury et al.,
determined to 2.8 Å resolution 46, 79. No crystallographic waters were present in this
crystal structure
The Influenza Virus Resource website 80 was used to search for sequences from
the NCBI Influenza Database of other Hong Kong H3N2 virus isolates. A phylogenetic
dendrogram was then built to enable the selection of influenza viruses with the least
similarity and most differences between the sequences. Six influenza viruses were
selected: A/Hong Kong/l/68 (H3N2), A/Hong Kong/l/69 (H3N2), A/Hong Kong/l/74
(H3N2), A/Hong Kong/l/75 (H3N2), A/Hong Kong/l/85 (H3N2), A/Hong Kong/l/92
(H3N2) and A/Hong Kong/l/99 (H3N2).
To construct the three-dimensional models of the six HAs, a multiple sequence
alignment of the viruses versus the A/Aichi/68 influenza HA of known structure was
done using NCBI -BLASTP 2.2.20+ 81 so as to find areas where mutations had taken
place. BLAST (Basic Local Alignment Search Tool) is an online program that finds
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regions of local similarity between sequences, by comparing nucleotide or protein
sequences to sequence databases and calculating the statistical significance of matches.
All the HAs and their complexes were then constructed using Swiss-PdbViewer (SwissPdb Viewer, also known as deep view, is an application that provides a user friendly
interface that allows analysis and modeling of several proteins at the same time 82) and
RasMol (molecular visualization software 83), from the initial coordinates of the
A/Aichi/68 (H3N2) HA–AB crystal structure. Amino acids were added, deleted or
replaced with residues manually to create mutated proteins. It was discovered that the
original PDB had some errors in residue numbering in the antibody (number 32 was
missing). A program was created by A. Poe (NMU Computer Science Department) to
correct this so that the numbering for all the atoms was consistent.

2.1.2 Structure Refinement
A preliminary pKa calculation was performed for all the starting structures of HA
and their complexes using the WebServer H++ 63, 65, which is an automated system that
computes pK values of ionizable groups in macromolecules and adds missing hydrogen
atoms according to the specified pH of the environment. The PDB files generated by the
H++ program were further edited after they were generated so that the LEaP program of
AMBER could correctly read them. Some of the changes that had to be made manually in
the PDB files included altering three letter abbreviations of Histidine, Lysine and
Cysteine. Histidine can exist either as the protonated species or as a neutral species with a
hydrogen at the delta or epsilon position. For this reason, the Histidine unit/residue name
is either HIP, HID, or HIE (but not HIS). The AMBER force fields also differentiate
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between the residue Cysteine (CYS) and similar residues that participates in disulfide
bridges, Cystine (CYX), substituting CYX for CYS in the sequence was thus done to
ensure correct disulfide bond creation. Aspartic acid--protonated ASH, Cystine, S--S
crosslink CYX, Histidine, delta H HID, Histidine, epsilon H HIE, Histidine, protonated
HIP. A general rule of thumb that was followed was to keep editing the input PDB file
until LEaP stopped reporting errors for all the structures.

Sodium ions/Chloride counter ions were then added to the HA-AB complex by
using a coulombic grid potential 59 via the LEaP module of AMBER to maintain the
system at charge neutrality. The grid potential positions the ions at the most energetically
favorable position near the protein. The system was then solvated using equilibrated
TIP3P water in a rectangular periodic box as a building block 62. The complex had at
least a 10 Å buffer in every direction of the box to permit substantial fluctuations of the
conformation during the course of the MD simulation.

2.2 Evaluation by Molecular Dynamics

To fix any errors introduced in the model-building process, the Sander module in
the AMBER 7 program package was used to carry out minimization and molecular
dynamics. The program relaxes the structure by iteratively moving the atoms down the
energy gradient until a sufficiently low average energy gradient is obtained.

Non–bond long range interactions were cut off at 12.0 Å and three stages of
minimizations performed to the water, hydrogens, amino acid side chains, and the entire
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structure; so as to remove initial steric clashes. The whole system (including protein (HA
alone or HA-AB complexes), water and hydrogen) was minimized with 200 steps of
minimizations. The protein atoms were then fixed, to allow only the water to move and
500 steps of minimization done in a constant volume periodic boundary to relax the
water. An additional 500 steps of minimization were then done on the whole system.

After minimization, the system was equilibrated in two stages. The protein
molecules were first fixed and the water molecules of the solvated systems equilibrated
using MD, and then the entire system equilibrated. Due to a problem with the AMBER
program (the program kept shutting down), the first stage of equilibration was skipped on
the HA-AB complex of 85, 92 and 99. At the beginning of each stage, the temperature of
the system was increased gradually from 10 K to 300 K with a 5 ps time constant for heat
bath coupling of the system. The target constant pressure of 1 atm was achieved and
maintained by isotropic position scaling, a coupling algorithm used in AMBER. A 0.002
ps time step was used. The Berendsen temperature coupling algorithm 84 was used to
maintain the system at its assigned temperature (300 K), with a scaling factor time
constant. All covalent bonds in the protein and in water were represented by constraints
that kept the bond distances to the proper chemicals values. The SHAKE algorithm 67
was used to fix the length of bonds containing a hydrogen atom to their equilibrium
values. Constraints were applied to all bonds involving hydrogen atoms of 0.2 Å. The
particle mesh Ewald 66 method was used to treat long range electrostatic interaction. To
minimize computational expense, long-ranged non-bonded interactions (van der Waals
interactions) were calculated out to a 12 Å residue-base cutoff distance.
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Before proceeding with the production MD run, temperature, density and total
energy versus time graphs were constructed to verify that the system had equilibrated.
From the figures, it was clear that the energy, temperature and density had all clearly
converged by the end of the equilibration period, and thus as a final step to the MD
simulations, 600 ps production simulation were performed at constant pressure and
temperature (300 K) after the system was equilibrated. A snapshot of the trajectory was
stored every ps (500 time steps) for later analysis. To allow for sufficient equilibration,
only the latter 500-ps of each 600-ps simulation were used for subsequent analysis of the
dynamics.
In all calculations, the AMBER 94 force field 55, 56 was used. The MD simulation
was performed using the AMBER suite of programs, version 7.0 85. Apart from what is
mentioned above, all other default settings were used in the simulations. Illustrations of
proteins were generated with the RasMol program 83. The different steps of the
simulations were performed partly on a parallel 2.8 GHz Pentium IV processor personal
IBM laptop computer, partly on a 2.2 GHZ Intel core 2 Duo Mac OS X laptop and partly
on a Beowulf cluster composed of a 32 node dual processor.

2.3 Energy Analysis: MM–PB (GB) SA Calculations
The MM-PB(GB)SA 75 method as implemented in AMBER 7 was used to
calculate the binding energy for non-covalent association of the influenza viruses and the
antibody. In the MM-PB(GB)SA method the average binding free energy (∆G bind) is
calculated as shown in Figure 9.
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Figure 9: The binding free energy (∆Gbind ) as defined by calculation from solute (∆Gsolute ) and
solvent (∆Gsolvation ) contributions. Total molecular mechanical energy of the solute (∆EMM)
represents average interaction energies obtained from performing calculations on ensemble of
uncorrelated snapshots from the equilibration MD; Electrostatic energy calculated from the
Coulomb potential (∆EELE); van der Waals distance-dependent interaction energy calculated from
the Lennard-Jones potential (∆EVDW); Internal energy from bonds, angles and torsions (∆EINT ,);
Electrostatic solvation contribution from solving the Generalized Born equation (∆GGB) or
Poisson Boltzmann equation (∆GPB) of MM (GB/PBSA) in Amber 7; ∆GSA is an empirical term
for the non-electrostatic contribution. γ is a surface tension parameter, and was set to 0.00542
00542 kcal mol-1 A-2 for PB and 0072 kcal mol-1 A-2 for GB ; SASA is the solvent-accessible
surface area determined by Sander’s LCPO method in Amber and β is a parameterized value, set
to 0.92 kcal mol-1 for PB and 0 for GB.

As shown in Figure 9, the free energy of any binding process may be divided into
a contribution from the solute and a contribution from the solvent:

G (X) = Gsolute (X) + Gsolvation (X)

The free energy contribution from the solvent and dissolved ions is calculated by
solving the linearized PB or GB equation for each of the three states, unbound
components and complex (gives the electrostatic contribution to the solvation free
energy) and adding an empirical term for the non electrostatic contribution, calculated
from the solvent–accessible surface area (SASA). This may be expressed as follows:
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∆Gsolvation (X) =∆GGB (X)+ ∆GSA (X)

∆GGB is the electrostatic contribution, obtained from PB or GB method.
∆GSA (X) is the non-electrostatic contribution calculated by
∆GSA (X) = γ (∆SASA) + β
γ is a surface tension parameter, and was set to 0.00542 kcal mol-1 Å -2 for PB and
0.0072 kcal mol-1 Å -2 for GB. SASA (X) is the solvent-accessible surface area of
molecule X, determined by Sander’s (Simulated annealing with NMR-derived energy
restraints. This allows for NMR refinement based on NOE-derived distance restraints,
torsion angle restraints, and penalty functions based on chemical shifts and NOESY
volumes) Linear Combinations of Pairwise Overlaps (LCPO) method 86. In this
experiment β is a parameterized value, set to 0.92 kcal mol-1 for PB and 0 for GB.

Calculating the average interaction energy between the receptor and the ligand
and taking the entropy change upon binding into account, if necessary, is how the free
energy contribution from the solute is obtained. This may be expressed as follows

∆Gsolute =∆EMM - T∆S

∆EMM = ∆EELE + ∆EVDW + ∆EINT

∆EMM represents the average interaction energies obtained from performing
calculations on an ensemble of uncorrelated snapshots collected from an equilibrated
molecular dynamics (MD) simulation where ∆EELE is the electrostatic energy calculated
from the Coulomb potential; ∆EVDW is the van der Waals distance-dependent interaction
energy calculated from the Lennard-Jones potential; ∆EINT is the internal energy due to
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bonds, angles and torsions. The entropy contribution (∆S) can be found by performing
normal mode analysis on the three species. However, entropy contributions are neglected
in this case as normal mode analysis calculations are computationally expensive and tend
to have a large margin of error that introduces significant uncertainty in the result.
Neglecting entropy contributions has been found to still produce fairly accurate results
when only a comparison of states of similar entropy is desired such as two ligands
binding to the same protein 74.

In principle, the calculation of the binding free energy described above would
require three independent MD simulations of the complex and both individual protein
(HA and antibody). This protocol is referred to as “separate trajectories” or “ three
trajectories” (3T) by Gohlke and Case 74. However an assumption was made that no
significant conformational changes occur upon binding i.e. structural adaptation is
negligible and the snap shots for all three species can be obtained from the single
trajectory carried out on the complex by separating the complex into its constituent parts
(Single Trajectory approach).

34

2.3.1 Generate Snapshots

To extract snapshots (without the water) from production runs for use in the MMPBSA 75 calculation, the mm_pbsa.pl script (provided in AMBER 7), that automates this
extraction process was used. Snapshots were generated for the complex as well as the
receptor by itself and the ligand by itself from the MD trajectory file for subsequent MMPB(GB)SA analysis. The input file used was the mm-pbsa.in (provided in AMBER 7).
This input file specifies which atoms are part of the receptor, ligand and complex as well
as specifying the total number of snapshots in the trajectories, the stride length, the names
of the trajectory files and the prmtop files corresponding to the unsolvated structures.
Prmtop files are topology files of the proteins that were created using LEaP after
stripping water from solvated PDB files. After executing the mm_pbsa.pl command,
approximately sixty equally spaced snapshots files were generated for the complex,
receptor and ligand, from the trajectory file. As noted above, it is preferable that the
snapshots are uncorrelated which is more likely if they are separated in time. The amount
of snapshots (sixty) was selected so as to complete the calculation in an average of three
days for each complex.
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2.3.2 MM-PB(GB)SA Binding Energy Calculation

Starting with the snapshots extracted, the interaction energy and solvation free
energy for complex, receptor and ligand were calculated and results averaged to obtain an
estimate of the binding free energy. The binding energy calculation for the process
A + B  AB i.e. the association of HA with AB to form the HA-AB complex was done
using both the MM-PBSA method and the MM-GBSA method for comparison. This was
accomplished by editing the input file for mm_pbsa.pl. Various portions of the input file
specify which calculations to run, on which files to run them and any special parameters
necessary to calculate the different contributions to the binding free energy. The ligand,
receptor, and complex were all turned on (specified to be included in calculations), and
the terms MM (Molecular Mechanics), GB, PB and MS(Molsurf) were computed for
each species (see below).

MM - Calculation of gas-phase energies using Sander
GB - Calculation of solvation free energies using the GB models in Sander
PB - Calculation of solvation free energies using Delphi (The PB method called by the
MM-PBSA, is implemented in the program Delphi). The Delphi program is not
distributed with AMBER and therefore was installed locally 87-90.
MS - Calculation of nonpolar contributions to solvation using Molsurf. MolSurf is a
program for the generation of molecular properties. MS = 0, in this study, so nonpolar
contributions were instead calculated with the LCPO method in Sander.

When finished, as expected, five output files were produced: binding_energy.log,
snapshot_statistics.out, snapshot_com.all.out, snapshot_rec.all.out, snapshot_lig.all.out.
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The all.out files gave the individual energy contributions for each of the snapshots for
each of the proteins (for the HA, antibody and complex, respectively) while the
statistics.out file contains the energy components for complex, HA and antibody
separately and the final averaged binding energy (under the category DELTA). A
calculation of the entropy contribution to binding was not done, so strictly speaking the
results of this study was not a true free energy value but could be used to compare similar
systems. The log file just indicated the success of the completed calculation.
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RESULTS

Six mutated influenza HAs and their antibody complexes were successfully
constructed and their change in binding energies calculated using the MM-PB(GB)SA
method. The six, A/Hong Kong H3N2 strains chosen were from 1969, 1974, 1975, 1985,
1992, and 1999. They were selected to give the widest possible spread of variant types as
shown by their dissimilarity to the original A/Hong Kong/l/68 (H3N2)-PDB (1EO8). This
was based on a Hong Kong influenza phylogenetic tree (Figure 10) that demonstrated
lack of similarity between the chosen influenza strains: A/Hong Kong/l/68 (H3N2),
A/Hong Kong/l/69 (H3N2), A/Hong Kong/l/74 (H3N2), A/Hong Kong/l/75 (H3N2),
A/Hong Kong/l/85 (H3N2), A/Hong Kong/l/92 (H3N2), A/Hong Kong/l/99 (H3N2). The
1999 HA was the most disimilar to the 1968 HA. Their HA-AB complexes were
constructed using the 1968 HA X-ray structure as a template.

Figure 10: Phylogenetic relationship between the seven Hong Kong HAs depicting an evolutionary
relationship and showing the lack of similarity between the chosen influenza isolates. The distance of one
group from the other groups indicates the degree of relationship i.e., the most similar sequence pairs
(Highest % sequence identity) are placed close together in a phylogenetic tree. Dissimilar pairs are placed
furthest apart. The length of the horizontal lines is proportional to the number of amino acid differences.
The 1999 HA is the most dissimilar to the 1968 HA.
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To construct the three-dimensional models of the six HAs, a multiple sequence
alignment of the HA protein sequences versus the A/Aichi/68 influenza virus of known
structure was done so as to locate areas where mutations had taken place. The sequence
alignment generated by NCBI–BLAST 81 is shown below in Figure 11 and the exact
mutations in Table 1. As expected, high similarity is observed between all the proteins
with the lowest sequence identity in a pair wise comparison found in antigenic sites of the
influenza HA proteins 34, 91.

Most of the mutations were conservative in terms of polarity (e.g., 147, Asn →
Ser, both polar amino acids or 137, Ile → Val, both hydrophobic). No conservation trend
was seen in size of amino acid or acidity (e.g. some amino acids changed from larger to
smaller one and others from basic to acidic or vice versa). The 1999 HA had the most
mutations (41 amino acids changed from previous year) followed by 85 HA (23), 92 HA
(14), 75 HA (10), 74 HA (9). The 1969 HA had the least (three).
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BLASTP 2.2.20+ RID: ZH0AE4G011N Query= gi|324132|gb|AAA43178.1| hemagglutinin
precursor [Influenza A virus (A/Aichi/2/1968(H3N2))] Length=566
ALIGNMENTS
Query
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Figure 11: The sequence
alignment results of the six
influenza HA viruses;
1969 HA (ABB80034), 1974
HA (ABB04294), 1985 HA
(ABB04928), 1992 HA
(ABB04349), and 1999 HA
(ABB04906, CAC40044) with
A/Aichi/68 (AAA43178) as
generated by BLASTP 2.2.20+.
Pink highlighted residues are
the antigenic sites described by
Wiley et. al 1.

Table 1: Color-coded table showing types of mutations. Yellow represents first time an amino acid mutates;
green, amino acid mutated/reverts back to the original amino acid; orange, second mutation; red, third
mutation from original; blue, amino acid mutates back to second mutation amino acid. The red number in
brackets indicates number of amino acid changes in that year, when compared to previous year on table.

COLOR CODED TABLE SHOWING TYPE AND NUMBER OF AMINO ACID
MUTATIONS IN EACH HAEMAGLUTININ
68

75

85

92

99

(3)

69

(9)

74

(10)

(23)

(14)

(41)

Leu

Leu

Leu

Met

68

69

74

75

85

92

99

162

Gly

Gly

Gly

Gly

Ser

Ser

Ser

13

Leu

Leu

Leu

14

Ala

Val

Val

Val

Val

Val

Val

171

Thr

Thr

Tyr

Tyr

Tyr

His

Tyr

15

Leu

Leu

Leu

Phe

Phe

Phe

Leu

175

Ser

Ser

Ser

Ser

Ser

Tyr

Asn

16

Gly

Gly

Gly

Ala

Ala

Ala

Gly

176

Thr

Thr

Thr

Thr

Lys

Lys

Thr

18

Asp

Asp

Asp

Asp

Lys

Lys

Asp

179

Val

Val

Val

Val

Val

Ala

Met

22

Asn

Asn

Asn

Asn

Asn

Asn

Lys

180

Leu

Leu

Leu

Gln

Leu

Leu

Leu

23

Asp

Asp

Asp

Asp

Asp

Asp

Gly

187

Asn

Asn

Asn

Asn

Asn

Asn

Ser

24

Asn

Asn

Asn

Asn

Asn

Asn

Asn

188

Asp

Asp

Asp

Asp

Gly

Asp

Asp

25

Ser

Ser

Ser

Ser

Ser

Ser

Asn

189

Asn

Asn

Asn

Asn

Lys

Lys

Gly

70

Asn

Asn

Asn

Asn

Ser

Ser

Asn

190

Phe

Phe

Phe

Ser

Phe

Phe

Phe

78

Ile

Leu

Ile

Ile

Lys

Lys

Ala

209

Ser

Ser

Asn

Asp

Asn

Ser

Asn

94

Val

Val

Gly

Gly

Gly

Gly

Gly

213

Gln

Gln

Gln

Gln

Arg

Arg

Gln

98

Glu

Glu

Glu

Glu

Glu

Lys

Glu

217

Arg

Arg

Arg

Lys

Lys

Lys

Lys

99

Thr

Thr

Lys

Lys

Lys

Glu

Lys

218

Val

Val

Val

Val

Val

Val

Ile

104

Val

Val

Val

Val

Val

Val

Ile

223

Arg

Arg

Lys

Lys

Lys

Lys

Lys

110

Phe

Phe

Phe

Phe

Phe

Tyr

Phe

229

Ile

Ile

Ile

Ile

Val

Val

Ile

121

Tyr

Tyr

Tyr

Tyr

Tyr

Tyr

His

264

Asn

Asn

Asn

Asn

Thr

Thr

Asn

137

Ile

Ile

Ile

Ile

Ile

Ile

Val

276

Met

Met

Met

Met

Ile

Ile

Val

138

Thr

Thr

Asn

Asn

Asn

Asn

Asn

277

Arg

Arg

Arg

Arg

Arg

Arg

His

140

Gly

Gly

Gly

Gly

Gly

Asp

Ser

289

Pro

Thr

Pro

Pro

Pro

Pro

Pro

142

Thr

Thr

Asn

Asn

Asn

Asn

Asn

291

Asp

Asp

Gly

Gly

Gly

Gly

Glu

144

Thr

Thr

Thr

Ile

Thr

Thr

Thr

294

Ile

Ile

Ile

Ser

Asn

Ser

Ser

147

Thr

Thr

Thr

Thr

Thr

Ala

Thr

492

Ala

Ala

Ala

Ala

Ala

Ala

Ser

148

Gln

Gln

Gln

Gln

Gln

Gln

Gln

520

Gly

Gly

Gly

Gly

Gly

Gly

Ser

149

Asn

Asn

Asn

Asn

Ser

Asn

Asn

315

Lys

Lys

Lys

Lys

Lys

Arg

Lys

153

Asn

Asn

Asn

Asn

Tyr

Tyr

Asn

323

Lys

Lys

Lys

Lys

Arg

Arg

Lys

159

Pro

Pro

Pro

Thr

Ser

Ser

Pro

324

Tyr

Tyr

Tyr

Tyr

Tyr

Tyr

Tyr

160

Gly

Gly

Asp

Asp

Val

Val

Asp

363

Ile

Ile

Ile

Ile

Val

Val

Val

161

Ser

Ser

Ser

Ser

Asn

Lys

Ser

547

Leu

Leu

Leu

Leu

Leu

Leu

Trp
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All the HAs and their complexes were constructed using Deep view and RasMol
from the initial coordinates of the A/Hong Kong/l/68 (H3N2)-PDB (1EO8) crystal
structure. As can be seen in Figure 12, the vast majority of mutations occur in the distal
sialic binding domain rather than in the long helical region. It makes sense that the
mutations would cluster in the antigenic region since changes to the protein structure in
these regions are likely to allow for escape from antibody. The bottom box in Figure 12 is
a representation of the simulation box of the full system of the 1968 HA-AB complex.
The protein had at least a 10 Å buffer in every direction of the rectangular periodic box.
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Figure 12: Ribbon representations of mono-subunits of the homo-trimmeric, hemagglutinin,
glycoprotein of the original 1968 HA, mutated 1999 HA, the 1968 HA-AB complex (from right to
left). The blue and red ribbons show the two distinct chains found in a mono-subunit of HA. The
magenta and cyan ribbons in HA-AB complex represent the light and heavy chain, respectively. The
yellow amino acids in the 1999 HA represent the mutated residues. The bottom box is a representation
of the simulation box of the full system of the 1968 HA-AB complex (the complex is represented by
red ribbons and water by blue wires). The total system size is 188605 atoms.

The preliminary pI calculations performed for both starting structures using the
WebServer H++, Sodium ions/Chloride counter ions added to the HA/HA-AB complex
and the total amount of water molecules added are shown in Table 2 below. The antibody
seems to be positively charged as it causes the complex to be more positive when
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compared to the HA alone. E.g., for the 1968 HA, charge at pH 6.5 is -3, when antibody
is added to form complex, total charge is +3. Earlier HAs have a more negative total
charge at pH 6.5 and lower isolectric point. The isolectric point and the total charge at pH
6.5 increases with year progression (lowest 1968, highest 1999). Interestingly, in the
1968 HA-AB complex, the HA is an anion while the AB is a cation, the proteins are thus
complementary and encourage binding. However by 1985, both proteins are cations and
binding would thus not be favorable. There also appears to be a change in protonation
state of some of the antibody’s amino acids upon HA, AB binding (HIS 196 and HIS
204); when in isolation the AB appears to have a + 8 charge, however, when in complex,
it has a +6 charge.

Table 2: The preliminary pI of starting structures for both the HA and their complexes calculated using
the WebServer H++ and total amount of waters and sodium/chloride ions added. Sodium ions/Chloride
counter ions were added to the HA-AB complex using the columbic grid of the LEaP module of AMBER,
and water added using an equilibrated TIP3P water in a rectangular periodic box as a building block. The
antibody seems to be positively charged as it causes the complex to be positive when compared to the HA
alone. Earlier HAs had a more negative total charge at pH 6.5 and lower isolectric points.
YR OF
Hong Kong/
H3N2

HAEMAGLUTININ ALONE

Total
charge at
pH 6.5

pI
68

6

-3

HAEMAGLUTIN-AB COMPLEX

N.O/Type
of ions
added in
leap

Total
number of
H2O added
in leap

3 Na+

Total
charge at
pH 6.5

pI

N.O/Type
of ions
added in
leap

8

3

3 Cl-

8

2

2 Cl-

8

4

4 Cl-

8

5

5 Cl-

9

9

9 Cl-

9

9

9 Cl-

9

13

13 Cl-

24996
69

6

-3

3 Na+

74

7

0

0

75

7

1

1 Cl-

85

9

6

6 Cl-

92

8

5

5 Cl-

99

9

6

6 Cl-

AB

9

6

8 Cl-

58169

24995

58168

25030

58091

25025

58086

26468

60018

26461
26945
17255
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Total
number of
H2O added
in leap

60001
59978

To obtain reliable estimates of absolute binding free energies, the average values
calculated by MM-PB(GB)SA had to be converged. After the equilibration run, density,
temperature, pressure and total energy data for all HA complexes were extracted from the
output files and combined to form continuous plots. It was confirmed that the systems
were equilibrated as all the values appeared to converge and the temperature had reached
the desired 300 K after 20 ps of equilibration (Figure 13). The average density was close
to the expected 1.0 gm/ml, which is appropriate for a protein solution, and the average
pressure was approximately 1 atm. Based on these plots it appears that the production
runs were stable and well behaved.
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Figure 13: The plots of the density, pressure and temperature (left) and potential (Eptot), kinetic (Ektot) and total Etot energy (right),
versus time, of the 1968 and 1969 HA-AB complex equilibration runs. The system was equilibrated in two stages (with the protein
molecules fixed first and then the entire system). Temperature was increased gradually from 10K to 300 K while maintaining constant
pressure. Berendsen algorithm was used to maintain system at its assigned temperature (300K). The graphs show that the systems had
been brought safely from 10K up to 300 K after 20 ps of run time and the density of the water box adjusted to ~1.0 grams/L. The values
on the Y-axis on the graphs on the right represent the temprature (K), pressure (atm) and density (gm/L), depending on what property is
being followed. The values on the Y-axis on the graphs on the left represent energy (kcal/mol).
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To further investigate the extent of equilibration, the root mean square deviation
(RMSD) in C -α position compared to the starting structure was determined as a function
of time. A typical RMSD plot is shown in Figure 14 for the simulation of the 1985
complex. It seems clear that there is a significant conformation shift occurring at about
250 ps. Based on the separate superposition of either just the antibody or just the HA
(also shown in Figure 14), it is clear that the conformational shift is due to HA not the
antibody. The B factor plot and RMSD plots of the 85 HA-AB complex seemed to
indicate that the AB was more flexible than HA and while the AB had reached an
equilibrated conformation state at around 100ps, HA had not (Figure 14). To further
clarify the nature of the conformational shift, a B-factor plot was prepared and is included
in Figure 14. For the HA, which represents residues 1- 566 in this plot, the most flexible
region is around residue 322 which suggests a change in conformation of the long helical
stalk which is far from the antigen binding site.
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Figure 14: B-factor plot and backbone RMSD plots of the 1985 HA-AB complex. B-factor plot (top left) and back bone RMSD plots of the 1985 HAAB complex (top right), AB from complex (bottom left) and HA from complex (bottom right). The B factor shows that the antibody is more flexible
than the HA. The RMSD plots show that while the AB had definitely reached equilibrium, HA had not.

The MM-PB(GB)SA method was used to average contributions of gas-phase
energies and solvation free energies calculated for snapshots of the HA–AB complex as
well as the unbound components, which were extracted from MD trajectories. The
binding free energy was obtained as the difference between the free energy of the
complex and the individual molecules. In our case, all water molecules were stripped, as
were all counter ions. Table 3 contains a free energy analysis showing energetic
contributions to the binding free energy of HA-AB, obtained for 60 snapshots of equal
spacing from the 500 snapshot MD trajectories of the HAs. Only 60 snapshots were
selected to ensure the binding energy calculations finished in a reasonable time frame i.e.
three days for each complex. The gas-phase energies included coulomb, van der Waals,
and internal energies. The solvation free energy is obtained as sum of a solvent-accessible
surface-dependent nonpolar contribution and a polar contribution from solving either the
PB or GB equations (see, Figure 9). In all cases ∆EINT is negligible which indicates
conformational changes upon binding did not lead to any internal strain.
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Table 3: Specific energy contributions to the binding free energy in kcal mol-1. Numbers in brackets represent standard deviations. ∆EELE, electrostatic
molecular mechanical energy contribution calculated from the Coulomb potential; ∆EVDW, van der Waals distance-dependent interaction energy
calculated from the Lennard-Jones potential; ∆EINT is the internal energy from bonds, angles and torsions; ∆EMM , total molecular mechanical Energy
(from generated snapshots); ∆GSolv, total solvation energy; ∆GGB HCT, electrostatic solvation contribution from solving the Generalized Born equation,
using the GB HCT model ( HCT refers to the GB method used (IGB=1). Further descriptions of this method may be found in the AMBER 7 manual);
∆GPB, electrostatic solvation contribution from solving the Poisson Boltzmann equation; ∆GBind(GB)/∆GBind(PB, binding free energy from GB or PB
method respectively.

Free Energy Analysis (Kcal mol-1) Binding of Influenza HA to the 68 HA antibody using the MMPB(GB)SA Method
∆EELE
∆EVDW
∆EINT
∆EMM

A/Hong
Kong/l/68(H3)
-272.11 31.06)
-84.58 (3.97)
0.01 (0.02)
-356.67(30.46)

A/Hong
Kong/l/69(H3)
-271.4(22.97)
-83.32(6.21)
0.02(0.02)
-354.7(22.35)

A/Hong
Kong/l/74(H3)
-19.06(21.63)
-80.68(4.84)
0.01(0.02)
-99.73(22.33)

A/Hong
Kong/l/75(H3)
22.56(30.95)
-87.98(5.27)
0.02(0.02)
-65.4(30.34)

A/Hong
Kong/l/85(H3)
98.07(27.96)
-94.61(5.53)
0.01(0.01)
-3.47(26.77)

A/Hong
Kong/l/92(H3)
80.54(17.78)
-85.77(2.41)
0.04(0.04)
-5.19(16.58)

A/Hong
Kong/l/99(H3)
297(12.61)
-95.14(5.62)
0
-201.86(10.73)

∆∆Gnp
∆∆GPB
∆∆GSolv
∆∆GPB,Elec
∆GBind(PB)

-10.00 (0.27)
322.50(28.80)
312.51(28.76)
50.39 (12.83)
-44.17(11.75)

-10.12(0.43)
306(18.76)
295.87(18.63)
34.59(15.9)
-58.83(13.04)

-9.19(0.34)
144.29(18.83)
135.1(18.68)
125.23(11.83)
35.37(11.35)

-9.79(0.39)
120.89(28.09)
111.09(27.86)
143.45(10.90
45.69(10.53)

-10.69(0.34)
85.71(20.95)
75.02(20.79)
183.78(15.28)
78.49(14.24)

-10.08(0.27)
56.23(21.84)
46.15(21.63)
136.78(6.49)
40.96(8.72)

-10.41(0.56)
-72.49(17.73)
-82.9(17.56)
224.51(14.98)
118.96(10.7)

∆∆Gnp,GBHCT
∆∆G GBHCT
∆∆GSolv, GBHCT
∆∆GGB,Elec
∆GBind(GB)

-12.06 (0.36)
302.00(28.17)
289.94(28.18)
29.89 (5.27)
-66.73 (5.49)

-12.23(0.57)
300.65(20.48)
288.42(20.5)
29.25(7.87)
-66.28(5.3)

-10.99(0.45)
66.53(18.29)
55.54(18.13)
47.47(5.98)
-44.19(6,54)

-11.79(0.52)
26.53(26.49)
14.75(26.18)
49.1(6.28)
-50.65(5.64)

-12.97(0.45)
-42.72(24.88)
-55.69(24.68)
55.35(6.14)
-52.22(4.89)

-12.17(0.36)
-27.72(15.56)
-39.89(15.25)
52.82(2.34)
-45.08(3.08)

-12.61(0.74)
-224.51(7.26)
-237.12(7.46)
72.49(7.28)
-35.25(5.44)

To test the internal consistency of the computations, binding free energy
calculations were repeated using only 5 snap shots of trajectories from 1969 HA. A
comparison of the results with values obtained for 60 snapshots indicates essentially
identical binding energy values (64.88 ± 6.1 kcal mol-1 vs. 66.28 ± 5.3 kcal mol-1)

Figure 15 shows the different energy contributions to the binding energy. ∆EELE
(electrostatic component from solute) is initially highly favorable for the 1968 HA
complex but becomes very unfavorable in later years. This reflects the change in net
charge of the HA as a result of the mutations. ∆EVDW (van der Waals component) favors
binding in all complexes and is fairly constant. ∆EINT (internal component) and ∆Gnp
(non-polar/non electrostatic contributions to solvation energy) have very little
contribution; ∆GGB or ∆GPBHCT (electrostatic contribution to the solvation energy
determined by the GB/PB equation), which are initially highly unfavorable, decrease with
time thus partially balancing the unfavorable change in ∆EELE. The 1992 HA (which also
did not follow the overall increase in number of mutations trend when compared to the
amount of mutations in the previous year) also showed a difference in trend in ∆EELE and
GGBHCT. The value becomes slightly less positive for ∆EELE than the previous year while
all the other HA values were more positive than the previous year. In addition, the value
became slightly less negative for GGBHCT than the 1985 HA while all the other GGBHCT
HA values were more positive than their prior year.
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Figure 15: The different energy contributions to the binding energy. ∆EELE (electrostatic component) progressively decreased favor of binding; ∆EVDW
(van der Waals component) favors binding in all viruses; ∆EINT (internal component) and ∆Gnp (non-electrostatic contributions to solvation energy),
very little contribution; ∆GGB/ ∆GPB (electrostatic contribution to the solvation energy determined by the GB/PB equation), decreased contribution with
time. HCT refers to the GB method used (IGB=1).

To show the trend of binding energy with year progression, as calculated by the
MM-GBSA method, a graph of binding energy versus time (year) was constructed
(Figure 16). The least negative binding energy (lowest antibody affinity) was displayed
by the 1999 HA while the original HA from the 1968 HA had the highest negative
change in binding energy (highest antibody affinity). This trend is consistent with the fact
that the antibody is specific for the 1968 HA and that later years can presumably escape
the antibody.

A graph was also constructed to show the trend of binding energy with year
progression as calculated using the MM-PBSA method (Figure 17). A similar pattern of
general decrease in binding affinity is seen with the least negative binding energy change
(lowest antibody affinity) by the 1999 HA but the the most negative change in binding
energy (highest antibody affinity) was by the 1969 HA mutant rather than the 1968 HA
as might be expected. However, the difference in binding energy between 1968 and 1969
is barely larger than the standard deviation in the binding energy calculation and
therefore the difference may not be significant.
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Figure 16: Graph showing change in free binding energy with increase in time/mutations, as calculated by MMGBSA. The 1968HA had the highest negative free energy change (-66.73 ± 5.49 kcal mol-1) while 1999 HA had
the lowest (35.25 ± 5.44 kcal mol-1). The error bars indicate standard deviation.

Figure 17: Graph showing the trend of binding energy with year progression as calculated using the MM –
PBSA. The least negative binding energy change (lowest antibody affinity) was by the 1999 HA (118.96 ±
10.7 kcal mol-1) while the 1969 HA (58.83 ± 13.83 kcal mol-1) had the most negative change in binding
energy (highest antibody affinity). The error bars indicate standard deviation.
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DISCUSSION

The sites of amino acid substitution in natural variants of HA from Hong Kong
H3 subtype viruses that were analyzed were scattered throughout the HA. However, as
suggested in various studies, most substitutions coincided with HA epitopes on proposed
antigenic sites that surrounded the conserved host-receptor binding site, while mutations
in the stalk were much less frequent 34. Taking into account that the antibody footprint is
larger than the receptor binding site, this is a very efficient way of preventing
neutralization of the influenza virus as it reduces binding of antibodies that target this
binding site without compromising its receptor binding function; which allows new virus
subtypes to spread within non immune species. That most of the “fixed changes” (i.e.
changes that were retained in HAs of isolated viruses in subsequent years), involved
residues on the surface membrane–distal globular domain of HA that surround the
receptor binding site whereas most of those that are not retained were found to be buried,
was also the general trend found in the HAs of the seven strains of the influenza viruses
analyzed. Fixed substitutions are thought to be naturally selected because they prevent
antibody binding 35.
The fact that simulations of all the seven HA-AB systems were carried out with
exactly the same computational procedures, allowed analytical comparisons to be made
between the binding energetics of Hong Kong HA isolates to the 1968 HA antibody,
over a period of twenty years. In line with the results of other studies 3, 44, 45, 92, binding
free energy became less favorable with increase in mutations, from 1968 to 1999 (-66.73
to -35.25 kcal mol-1). Fleury et al 46 also found that a HA wild type specific antibody still
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bound to three escape mutant HAs, but with a much reduced affinity i.e. between Kd 4 ×
10−6 M and 5 × 10−7 M. This was significantly lower than its affinity for the wild-type
HA (Kd 10−9 M) 3. However, the results of the MM-PBSA study show that there was no
increase in antibody binding affinity after twenty years of mutations. The 1968 HA had
most favorable change in free energy binding energy through the twenty years (-66.73
kcal mol-1). This may be due to continuous pressure by the original 1968 antibody on new
mutated viruses, in addition to their own HA specific antibodies. That is, if any of the
earlier 1968 HA viruses were still circulating in the human population, antibodies against
it would also be present; new viruses would therefore try to mutate to prevent strong
binding by these antibodies as well as their most immediate-specific antibody.
Interestingly, despite the overall positive trend of decrease in energy, the sequential
mutations showed a significant fluctuation in binding energy. This might be additional
proof that the mutations are random but self-corrective in nature. Sites where amino acid
changes can alter antigenicity are so limited that in some strains key amino acids in these
sites changed for the second time as evolution proceeded while some reverted back.
Presumably, at any stage in the evolution of a viral subtype, several different strains may
be circulating simultaneously and the combination of changes that are most favorable to
the virus would be ones that are preserved during evolution 17, 31. Successful strains
dominate and thus become progenitors for future generations; these are ones that have
HAs that don’t bind too tightly to currently available antibodies.
A search of available literature did not result in any articles that indicated any
general preference of amino acid by a larger or different side chain for mutations. This
was the case in this study. However, from a quick look at the types of mutations of the
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HAs analyzed, it seems there were was a general conservation of mutations in terms of
polarity i.e. a polar amino acid was substituted with another polar amino acid. In addition
it has been suggested that oligosaccharide attachment also prevents antibody recognition
93

. This could be due to the inability of carbohydrate covered protein side chain surfaces

to induce antibodies, as the carbohydrates side chains are synthesized by cellular
enzymes and are thus “antigenically self”. They thus mask regions of proteins from
recognition by antibody. It should be noted that the lack of information on the crystalline
structure of oligosaccharide attachments in HA herein studied, implies that the analysis of
these attachments were not included as part of this study. This is despite the fact that
since the beginning of the Hong Kong pandemic period in 1968, a study of the recent
changes in influenza virus showed an increase in the number of oligosaccharide
attachment sites (especially on the membrane distal domain of HA). While the Hong
Kong HA monomer in 1968 had a total of three attachment sites (at position 81, 165,
285), this number had increased to eight by 2005 (63, 122, 126, 133, 144, 165, 246 and
285) 23, 94. A study of the role of oligosaccharide attachment in reduction in binding
affinity would be beneficial in better predicting the trend in amino acid substitution
during HA antigenicity.
Detailed analyses of the binding energetics of influenza HA to the 1968 antibody
allows better understanding of the contribution of different energy terms to the binding
free energy. The association of the antibody and HA is driven by highly favorable van der
Waals interactions (∆EVDW), the most important and consistent complex formation
favoring term (Figure 15). This being the case, it is surprising to note that its contribution
is constant and does not decrease with time to allow the virus to more easily escape
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antibody binding. In all seven HA-AB complexes investigated, the van der Waals
interactions for HA binding were between -80.6 and -94.6 kcal mol-1. In line with the
results of this work, the non-covalent association has been found to be driven by
favorable van der Waals energies in several MM-PBSA studies 75 .
In contrast to van der Waals energies, electrostatic energies contributed unequally
to the binding of the HA virus strains to the 1968 antibody. That the unfavorable
electrostatic solvation is compensated, but not fully, by favorable electrostatic protein–
ligand interactions has been observed in several earlier ligand-binding studies and seems
to be a general phenomenon 75, 76. In agreement with earlier computational ligand binding
studies, the solvation electrostatic energies (∆∆Gelec, PB/ GB) are mostly unfavorable for
binding, but the degree at which the energy disfavors binding, decreases with year
progression. For example by 1999 the solvation electrostatic energy favors binding
compared to 1968 when it disfavors binding. The exact opposite effect is seen with solute
electrostatic energies (∆∆EELE). While in the 1968 and 1969 HA the energies favor
binding, by 1999 the energies disfavor binding. Thus, electrostatic interactions determine
the specificity in the binding of influenza HA to antibody. Solvent effects are most
important when the binding between HA and antibodies is less strong. Looking back at
the total charges of the modeled HAs (Table 1), mutations seem to favor amino acids that
make the HA more positively charged (3 for 68 vs. +6 for 99). This could account for the
∆EELE, electrostatic molecular mechanical energy contribution calculated from the
Coulomb potential becoming more positive with year progression (thus disfavoring
complex formation). Less favorable solute energies due to the preference of more
positively charged amino acids during mutation could hint to a strategy used by influenza
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viruses to escape antibody binding. Analyses of more viruses should provide more
evidence of this trend 95. Similar to other studies 74, 77, both internal energy (∆EINT) and
non-electrostatic energies contribution to solvation (∆∆Gnp) are very small and contribute
minimally to the complex formations.
The MM-GBSA calculations of the study seem to over estimate the relative free
binding energy of influenza HA to antibody when compared to the limited available
experimental values (12 kcal mol-1 3) and other free energy computational studies (36 vs.
66 kcal mol- 196). However, in view of the fact that the accuracy of absolute binding free
energy calculations depends on a delicate balance of different energetic and entropic
contributions, the calculated binding free energy can still be considered close to the
experimentally determined one. In addition, for the purpose of this study, we were more
interested in the trend of binding energies (qualitative) than the exact values
(quantitative). Therefore, if we assume that all values were over estimated by the same
degree, the conclusions that the trend shows a decrease in negative binding energy with
increase in mutations, remains valid. It should also be noted that the study involved
stimulation of the HA monomer and not the whole homotrimmer, as it is found in nature.
This could have also contributed to the difference in results.
Calculations of the binding free energies of the HA–AB for snapshots extracted
from the single complex trajectory versus three trajectories calculations might have
contributed to the difference in values from those that have previously described in
experiments. The method was chosen because it is less time consuming than using
snapshots from three separate trajectories and potentially requires less sampling, because
all of the intramolecular energies cancel when calculating the association energy. Related
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studies applying MM-PB(GB)SA for the prediction of absolute binding affinities have
shown good agreement between values calculated for snapshots extracted either from the
complex trajectory or from all three trajectories. However, Gohlke et al 74, 97 showed that
the single trajectories approach is only completely successful, if no conformational and
dynamical changes upon complex formation occur in the binding partners. In the case of
the influenza HA although there has been some evidence of conformational change upon
binding 48, 98, this has not been proven. RMSD and B-Factor plots made of the 1968 HA
and 1985 HA (Figure 14) suggest that although the antibody is more flexible than the HA
during the simulation, the HA is undergoing a more significant conformation shift and is
taking longer to equilibrate. If conformational change does take place, it would account
for some of the disparity between the calculated binding free energies and the
experimental values available.
Another minor complication that resulted was that despite a similar qualitative
pattern in binding energy data being realized in both GB and PB methods (which as
mentioned earlier is what was most important in this study), a difference in quantitative
data was obtained by the GB and PB method. The difference in values of binding
energies by the PB or GB method results from a difference in calculation of the
electrostatic energies by solving the respective equations, as shown in Table 3. The
difference could be due to choice of parameters. Upon HA-AB complex formation, polar
and charged residues become buried in the binding interface. Modeling of the desolvation
penalty and correctly estimating screened electrostatic interactions between both proteins
is therefore crucial for the accurate estimation of binding affinity. Free energy
contributions can be calculated by solving the Poisson-Boltzmann equation using radii
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from the PARSE parameter set (PB-linearized or PB-non-linearized) Bondi radii or by
solving the General Born equation by applying generalized Born models of Jayaram et al.
(MGB/GB JSB) 99, Onufriev et al. (GBOBC) 100, and Tsui et al (GBHCT) 101. The different
models using the different parameter sets produce different results as shown by Golkhe
and Case 74 who tested the internal consistency and the model dependence influence of
different continuum solvation models on the absolute binding free energy of Ras-Raf .
They found that calculated absolute binding free energies strongly depend on the applied
solvation model and were within a range of 6.2 kcal mol-1 (from PB equation using an
linearized PARSE parameter) to -49.4 kcal mol-1 (from GB equation using Tsui et al
(GBHCT) solvation model). The results obtained using different GB models in connection
with a solvent-accessible surface area-dependent term (to estimate nonpolar solvation
energies) overestimated the binding affinity of Raf towards Ras, whereas PB calculations
yielded binding free energies that were either too positive or too negative, depending on
the atomic radii applied. Studies have shown that using the GBOBC would result in the
results that are most similar to PB results. This is not unexpected, because GBOBC has
been modified to give better agreement between PB and GB results for RAS-RAF
binding. It is thought that PB gives values that are closest to experimental values. No
studies were found that showed the same agreement in values between the PB and GB
method when using the GBOBC model in other protein-antibody systems. In this study, the
GBHCT model was chosen for the GB calculation, as it was the only model that worked
with the current parameter set and system set up. This could be due to the AMBER
version used as some of the GB models require later versions of AMBER.
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Further testing and parameterizations across large sets of systems with different
properties will be necessary to probe the transferability of the protocols and further
improve parameters for influenza. It will be interesting to evaluate the influence of recent
developments in the field of polarizable force fields and continuum solvent descriptions
on the outcome of these calculations.
Even though the basic idea is simple, the art of MD was challenging in practice as
the results of a MD simulations can only be as good as the governing force field. The
functional forms of force fields employed in the molecular mechanics were a compromise
between accuracy and computational efficiency. For example, that the calculated binding
free energies were larger than those obtained by experiment may have also been caused
by the short time scale of the MD simulations. Also due to the computational demand, the
calculations were reported for 60 snapshots from the set of 500 extracted from
trajectories. Studies done using only a subset of snapshots did not lead to a significant
change of the calculated binding free energy compared to the one obtained for the total
set; but there was an increase in standard deviation. These simplifications meant that the
MD simulations of the trajectories needed for energy analyses was by today’s standards a
computationally inexpensive tasks, making screening of the multiple influenza complexes
feasible in a limited amount of time.
Other various techniques that could be used to predict relative binding free
energies of protein-protein association include free energy perturbation (FEP) 95 and
linear interaction energy (LIE). FEP and other similar computer simulation techniques,
such as thermodynamic integration, offer a rigorous statistical mechanical way to
calculate free energies of binding. However, for the purpose of this study, they were not
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conducive as they also suffer from long computational times and technical difficulties
associated with creation and annihilation of atoms and have typically been used for single
mutation studies. Also for an LIE calculation experimental binding data is needed to fit
against in order to do the calculation, which is rarely available 102. Compared to the more
traditional Free Energy Perturbation (FEP) simulations, the MM–PBSA method is a
slightly less accurate but a considerably faster approach. However, it is important to note
that although the FEP methods can be applied reliably only to relatively small mutations,
it in favorable cases provides free energies at chemical accuracy (i.e. within 1 kcal mol-1
from experiment). However, this accuracy would not have been beneficial in the case of
this study since the computing time for similar study using FEP would be too expensive
and this study involved doing multiple mutations.

The success in calculating and summarizing the relative binding free energies of
the HAs indicates that the MM-PBSA method is a fairly reliable tool to investigate virusantibody interaction that is not too computer time expensive. The results show that
antigenic drift of influenza viruses caused by gradual mutations to the HA gene
continually produce immunologically distinct strains that bind less tightly to the specific
antibody. Since the emergence of such new drift variants underlines the importance of
influenza virus surveillance, the effectiveness of influenza vaccinations may be greatly
reduced when there is a significant antigenic mismatch between vaccine strains and
circulating viruses 103. Although our data does provide a bit more insight on the trend of
mutations, neither antigenic nor energetic analysis alone can give sufficient information
on the route of evolution of influenza viruses. Therefore, additional antigenic as well as
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genetic characterization of currently circulating influenza viruses is required for
determining the most appropriate composition of new influenza vaccines.
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